相关实验视频

Updated: Jun 12, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

局部除性免疫疗法通过调节瘤透性马三角形T细胞的转录组来增强抗瘤免疫力

Kaili Liu¹, Ashley R Hoover², Lin Wang¹

¹Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, USA.

|September 22, 2024

概括

激光消灭性免疫疗法 (LAIT) 增强乳腺瘤中的马三角T细胞 (γδT细胞),增强抗瘤免疫力. 这种新型疗法增加了产生IL17的γδT细胞,表明了与免疫检查点抑制剂的潜在协同作用,以改善癌症治疗.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

马三角形T细胞 (γδT细胞) 对于抗瘤免疫至关重要,但它们在癌症治疗中的功能尚未完全理解.
激光 Ablative 免疫疗法 (LAIT),结合光热疗法 (PTT) 和 N-dihydrogalactochitosan (GC),显示出消除瘤和转移的希望.

研究的目的:

在乳腺癌小鼠模型中研究LAIT对瘤透的γδT细胞的影响.
在LAIT治疗后表征 γδT 细胞亚型及其转录组特征.

主要方法:

单细胞RNA测序 (scRNAseq) 用于分析使用对照,PTT,GC或LAIT治疗的瘤中的γδT细胞.
进行了差异基因表达分析,以确定 γδT 细胞中的分子变化.
使用TCGA数据将gDT细胞亚型与患者存活率相关联.

主要成果:

实验室确定了六种γδT细胞亚型:激活型,细胞毒性,循环细胞毒性,IFN丰富型,抗原呈现型和IL17产生型.
莱特高调调节了与T细胞激活,白细胞粘附和干扰素信号传递相关的基因.
LAIT 独特地增加了 IL17 产生 γδT 细胞,与更好的乳腺癌患者存活率有关.

结论:

LAIT有效调节 γδT 细胞转录组,增强它们的抗瘤功能.
用LAIT治疗的γδT细胞的转录形状类似于用免疫检查点抑制剂 (ICI) 治疗的患者的细胞.
莱特具有与ICI结合治疗的潜力,以改善癌症治疗结果.

关键词:

乳腺癌乳腺癌乳腺癌局部废除性免疫治疗局部废除性免疫治疗 N-dihydrogalactochitosanosan 的使用方法单细胞RNA测序的一个细胞.γδT细胞激活的过程

更多相关视频

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...